204 related articles for article (PubMed ID: 28616936)
1. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
5. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
[TBL] [Abstract][Full Text] [Related]
6. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
7. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.
Winstead M; Sun PP; Martin K; Earl J; Neumayr L; Hoppe C; Vichinsky E
Pediatr Hematol Oncol; 2017 Mar; 34(2):100-106. PubMed ID: 28532265
[TBL] [Abstract][Full Text] [Related]
8. Reoperation for moyamoya disease refractory to encephalo-duro-arterio-synangiosis.
Matsushima T; Fujiwara S; Nagata S; Fujii K; Fukui M; Hasuo K
Acta Neurochir (Wien); 1990; 107(3-4):129-32. PubMed ID: 2077849
[TBL] [Abstract][Full Text] [Related]
9. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
12. Multiple EDAS (encephalo-duro-arterio-synangiosis). Additional EDAS using the frontal branch of the superficial temporal artery (STA) and the occipital artery for pediatric moyamoya patients in whom EDAS using the parietal branch of STA was insufficient.
Tenjin H; Ueda S
Childs Nerv Syst; 1997 Apr; 13(4):220-4. PubMed ID: 9202858
[TBL] [Abstract][Full Text] [Related]
13. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
14. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
15. Indirect revascularization for pediatric moyamoya disease.
Ogawa S; Ogiwara H
J Neurosurg Pediatr; 2024 Jul; 34(1):111-117. PubMed ID: 38608297
[TBL] [Abstract][Full Text] [Related]
16. Angiographic demonstration of cerebral revascularization after encephalo-duro-arterio-synangiosis (EDAS) performed on pediatric moyamoya patients.
Matsushima Y; Aoyagi M; Fukai N; Tanaka K; Tsuruoka S; Inaba Y
Bull Tokyo Med Dent Univ; 1982 Mar; 29(1):7-17. PubMed ID: 6961966
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment for paediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS).
Matsushima T; Fujiwara S; Nagata S; Fujii K; Fukui M; Kitamura K; Hasuo K
Acta Neurochir (Wien); 1989; 98(3-4):135-40. PubMed ID: 2741743
[TBL] [Abstract][Full Text] [Related]
18. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease.
Kim SK; Wang KC; Kim IO; Lee DS; Cho BK
Neurosurgery; 2002 Jan; 50(1):88-96. PubMed ID: 11844238
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis.
Isono M; Ishii K; Kamida T; Inoue R; Fujiki M; Kobayashi H
Pediatr Neurosurg; 2002 Jan; 36(1):14-21. PubMed ID: 11818741
[TBL] [Abstract][Full Text] [Related]
20. Childhood moyamoya disease before and after encephalo-duro-arterio-synangiosis: an angiographic study.
Yamada I; Matsushima Y; Suzuki S
Neuroradiology; 1992; 34(4):318-22. PubMed ID: 1528443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
